Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression.

Narita S, Nara T, Sato H, Koizumi A, Huang M, Inoue T, Habuchi T.

J Clin Med. 2019 Apr 30;8(5). pii: E597. doi: 10.3390/jcm8050597. Review.

2.

Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis.

Koizumi A, Narita S, Nara T, Takayama K, Kanda S, Numakura K, Tsuruta H, Maeno A, Huang M, Saito M, Inoue T, Tsuchiya N, Satoh S, Nanjo H, Habuchi T.

Jpn J Clin Oncol. 2018 Aug 1;48(8):765-770. doi: 10.1093/jjco/hyy092.

PMID:
29931077
3.

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.

Numakura K, Fujiyama N, Takahashi M, Igarashi R, Tsuruta H, Maeno A, Huang M, Saito M, Narita S, Inoue T, Satoh S, Tsuchiya N, Niioka T, Miura M, Habuchi T.

Oncotarget. 2018 May 18;9(38):25277-25284. doi: 10.18632/oncotarget.25423. eCollection 2018 May 18.

4.

Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production.

Huang M, Narita S, Inoue T, Koizumi A, Saito M, Tsuruta H, Numakura K, Satoh S, Nanjo H, Sasaki T, Habuchi T.

Oncotarget. 2017 Dec 4;8(67):111780-111794. doi: 10.18632/oncotarget.22908. eCollection 2017 Dec 19.

5.

Host-related Risk Factors for Adherent Perinephric Fat in Healthy Individuals Undergoing Laparoscopic Living-donor Nephrectomy.

Narita S, Kumazawa T, Tsuchiya N, Mingguo H, Saito M, Inoue T, Tsuruta H, Numakura K, Maeno A, Nanjo H, Satoh S, Habuchi T.

Surg Laparosc Endosc Percutan Tech. 2017 Aug;27(4):e69-e73. doi: 10.1097/SLE.0000000000000433.

6.

Inverse relationship between insulin receptor expression and progression in renal cell carcinoma.

Takahashi M, Inoue T, Huang M, Numakura K, Tsuruta H, Saito M, Maeno A, Nakamura E, Narita S, Tsuchiya N, Habuchi T.

Oncol Rep. 2017 May;37(5):2929-2941. doi: 10.3892/or.2017.5552. Epub 2017 Apr 5.

PMID:
28393204
7.

Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.

Takayama K, Inoue T, Narita S, Maita S, Huang M, Numakura K, Tsuruta H, Saito M, Maeno A, Satoh S, Tsuchiya N, Habuchi T.

Cancer Lett. 2017 Jul 1;397:103-110. doi: 10.1016/j.canlet.2017.03.034. Epub 2017 Mar 31.

PMID:
28373003
8.

The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".

Ito R, Narita S, Huang M, Nara T, Numakura K, Takayama K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T.

PLoS One. 2017 Feb 8;12(2):e0171615. doi: 10.1371/journal.pone.0171615. eCollection 2017.

9.

Altered miRNA expression in high-fat diet-induced prostate cancer progression.

Nara T, Narita S, Mingguo H, Yoshioka T, Koizumi A, Numakura K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T.

Carcinogenesis. 2016 Dec;37(12):1129-1137. Epub 2016 Oct 7.

PMID:
27915273
10.

Efficacy and safety of bladder hydrodistension for decreased bladder capacity induced by intravesical BCG therapy.

Numakura K, Tsuchiya N, Tsuruta H, Akihama S, Saito M, Inoue T, Narita S, Huang M, Satoh S, Habuchi T.

Scand J Urol. 2016 Dec;50(6):429-432. Epub 2016 Oct 5.

PMID:
27701987
11.

Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib.

Numakura K, Tsuchiya N, Kagaya H, Takahashi M, Tsuruta H, Inoue T, Narita S, Huang M, Satoh S, Niioka T, Miura M, Habuchi T.

Anticancer Drugs. 2017 Jan;28(1):97-103.

PMID:
27564227
12.

Clinical benefits of tubeless umbilical cutaneous ureterostomy.

Numakura K, Tsuchiya N, Takahashi M, Tsuruta H, Akihama S, Saito M, Inoue T, Narita S, Huang M, Satoh S, Habuchi T.

Can Urol Assoc J. 2015 May-Jun;9(5-6):E379-83. doi: 10.5489/cuaj.2559.

13.

INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.

Kofuji S, Kimura H, Nakanishi H, Nanjo H, Takasuga S, Liu H, Eguchi S, Nakamura R, Itoh R, Ueno N, Asanuma K, Huang M, Koizumi A, Habuchi T, Yamazaki M, Suzuki A, Sasaki J, Sasaki T.

Cancer Discov. 2015 Jul;5(7):730-9. doi: 10.1158/2159-8290.CD-14-1329. Epub 2015 Apr 16.

14.

De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: a case report.

Numakura K, Satoh S, Tsuchiya N, Saito M, Nara T, Huang M, Tsuruta H, Akihama S, Inoue T, Narita S, Habuchi T.

Prog Transplant. 2014 Dec;24(4):328-31. doi: 10.7182/pit2014372.

PMID:
25488554
15.

Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma.

Numakura K, Tsuchiya N, Akihama S, Inoue T, Narita S, Huang M, Satoh S, Habuchi T.

Oncol Lett. 2014 Jul;8(1):464-466. Epub 2014 May 7.

16.

Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.

Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.

Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952. Epub 2014 May 20.

17.

Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer.

Chiba S, Tsuchiya N, Horikawa Y, Narita S, Inoue T, Akihama S, Saito M, Numakura K, Tsuruta H, Huang M, Satoh S, Habuchi T.

Int J Oncol. 2014 Mar;44(3):678-84. doi: 10.3892/ijo.2013.2221. Epub 2013 Dec 20.

PMID:
24366484
18.

Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression.

Huang M, Narita S, Inoue T, Tsuchiya N, Satoh S, Nanjo H, Sasaki T, Habuchi T.

Endocr Relat Cancer. 2013 Dec 16;21(1):39-50. doi: 10.1530/ERC-13-0227. Print 2014 Feb.

PMID:
24344250
19.

Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.

Tsuchiya N, Narita S, Inoue T, Saito M, Numakura K, Huang M, Hatakeyama S, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.

BMC Cancer. 2013 Mar 25;13:150. doi: 10.1186/1471-2407-13-150.

20.

A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.

Huang M, Narita S, Numakura K, Tsuruta H, Saito M, Inoue T, Horikawa Y, Tsuchiya N, Habuchi T.

Prostate. 2012 Dec 1;72(16):1779-88. doi: 10.1002/pros.22531. Epub 2012 Apr 18.

PMID:
22514016

Supplemental Content

Loading ...
Support Center